chi News

Cambridge Healthtech Institute & Bio-IT World organizes a dinner short course on June 6, 2012 at the Royal Sonesta Hotel Boston in Cambridge, MA. The course will be held at the conclusion of day one of the Structure-Based Drug Design conference.

Hear breakthroughs in the field of pathology such as predictive cancer biomarkers, decoding cancer molecular profiles, next generation sequencing, circulating tumor cells, etc. View final agenda at www.healthtech.com/tdx.

100+ pharma and biotech companies from around the world will participate at CHI's 4th annual Integrated R&D Informatics & Knowledge Management conference to be held in San Francisco, CA on February 21-23, 2012.

Badri Rengarajan, M.D., Medical Director, will present in the modeling and simulation tools to improve Phase III success session.

Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session.

Dr. Leach will participate in a keynote session at this conference scheduled for Feb. 21-23, 2012, San Francisco, CA. The conference is organized by Cambridge Healthtech Institute.

Dr. Craig Jordan announces presentation at upcoming symposium on February 19-20, 2012 in San Francisco, CA.

This conference is part of the Molecular Med TRI-CON 2012 event on February 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA. Advance registration discounts ends on January 13.

Dr. Williams will present on evidentiary standards for surrogate endpoints, genetic testing & CDx.

CHI’s Bioinformatics & Cancerinformatics conference is a new program being held at the Molecular Med TRI-CON 2012 on Feb. 21-23 at the Moscone in San Francisco. This conference is part of the many program options available at the Tri-Conference.

Amarin’s CMO to lead line-up of thought leaders at Cambridge Healthtech Institute’s executive and scientific forum.

Incredibly priced deals guaranteed--just in time for the holidays.

CHI confirms new speakers for its keynote session on cancer clinical trials in the era of personalized medicine lead by Roche Holding AG, UCSF Helen Diller Family Comprehensive Cancer Center, and Samuel Oschin Comprehensive Cancer Institute.

Cambridge Healthtech Institute just adds an interactive panel discussion to take place at its Integrated R&D Informatics & Knowledge Management conference on Feb. 21-23, 2012, San Francisco, CA.

Cambridge Healthtech Institute’s (CHI) BioPharma Strategy Series is proud to present the first conference on Phase III Clinical Trials: Strategic Decisions for Successful Drugs to be held in Philadelphia, PA on March 12-13, 2012.

When: November 17-18, 2011 Where: Omni Parker House - Boston, MA

CHI’s Oncology Clinical Trials conference will highlight two case studies by Seattle Genetics’ Eric Sievers, M.D., Vice President, Clinical Affairs, and Elaine S. Waller, Pharm.D., M.B.A., Senior Vice President, Regulatory Affairs.

CHI’s Oncology Clinical Trials conference will highlight three Zelboraf case studies by Genentech, F. Hoffmann-La Roche, and Roche Molecular Systems. This conference is part of the many program options available at the Tri-Conference.

CHI’s Integrated R&D Informatics conference will once again be held at the Molecular Med TRI-CON 2012 on Feb. 21-23, 2012 at the Moscone in San Francisco, CA. This conference is part of the many program options available at the Tri-Conference.

Adelphi has officially launched the CHI, a cornerstone of the University’s comprehensive strategic plan. The Center seeks to tackle and improve current and emerging healthcare needs and make Adelphi an even stronger thought leader in healthcare.

Cambridge Healthtech Institute & Bio-IT World organizes a two hour dinner short course on June 7, 2012, Royal Sonesta Hotel Boston, Cambridge, MA. The course will be held at the conclusion of day two of the Structure-Based Drug Design conference.

This course will be held on June 4, 2012, Loews Hotel, Philadelphia, PA. The course will be held prior to the start of CHI’s Innovative Tissue-Based Diagnostics conference.

Cambridge Healthtech Institute & Bio-IT World organizes a dinner short course on June 6, 2012 at the Royal Sonesta Hotel Boston in Cambridge, MA. The course will be held at the conclusion of day one of the Structure-Based Drug Design conference.

Hear breakthroughs in the field of pathology such as predictive cancer biomarkers, decoding cancer molecular profiles, next generation sequencing, circulating tumor cells, etc. View final agenda at www.healthtech.com/tdx.

100+ pharma and biotech companies from around the world will participate at CHI's 4th annual Integrated R&D Informatics & Knowledge Management conference to be held in San Francisco, CA on February 21-23, 2012.

Badri Rengarajan, M.D., Medical Director, will present in the modeling and simulation tools to improve Phase III success session.

Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session.

Dr. Leach will participate in a keynote session at this conference scheduled for Feb. 21-23, 2012, San Francisco, CA. The conference is organized by Cambridge Healthtech Institute.

Chris Porter, Product Manager, HPC Cloud, will lead a luncheon presentation at CHI’s Cloud Computing: Applications and Advances in Life Sciences R&D Symposium next month in San Francisco, CA.

Dr. Craig Jordan announces presentation at upcoming symposium on February 19-20, 2012 in San Francisco, CA.

This conference is part of the Molecular Med TRI-CON 2012 event on February 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA. Advance registration discounts ends on January 13.

Dr. Williams will present on evidentiary standards for surrogate endpoints, genetic testing & CDx.

CHI’s Bioinformatics & Cancerinformatics conference is a new program being held at the Molecular Med TRI-CON 2012 on Feb. 21-23 at the Moscone in San Francisco. This conference is part of the many program options available at the Tri-Conference.

Amarin’s CMO to lead line-up of thought leaders at Cambridge Healthtech Institute’s executive and scientific forum.

Incredibly priced deals guaranteed--just in time for the holidays.

CHI confirms new speakers for its keynote session on cancer clinical trials in the era of personalized medicine lead by Roche Holding AG, UCSF Helen Diller Family Comprehensive Cancer Center, and Samuel Oschin Comprehensive Cancer Institute.

Cambridge Healthtech Institute just adds an interactive panel discussion to take place at its Integrated R&D Informatics & Knowledge Management conference on Feb. 21-23, 2012, San Francisco, CA.

Cambridge Healthtech Institute’s (CHI) BioPharma Strategy Series is proud to present the first conference on Phase III Clinical Trials: Strategic Decisions for Successful Drugs to be held in Philadelphia, PA on March 12-13, 2012.

When: November 17-18, 2011 Where: Omni Parker House - Boston, MA

CHI’s Oncology Clinical Trials conference will highlight two case studies by Seattle Genetics’ Eric Sievers, M.D., Vice President, Clinical Affairs, and Elaine S. Waller, Pharm.D., M.B.A., Senior Vice President, Regulatory Affairs.

CHI’s Oncology Clinical Trials conference will highlight three Zelboraf case studies by Genentech, F. Hoffmann-La Roche, and Roche Molecular Systems. This conference is part of the many program options available at the Tri-Conference.

CHI’s Integrated R&D Informatics conference will once again be held at the Molecular Med TRI-CON 2012 on Feb. 21-23, 2012 at the Moscone in San Francisco, CA. This conference is part of the many program options available at the Tri-Conference.

Adelphi has officially launched the CHI, a cornerstone of the University’s comprehensive strategic plan. The Center seeks to tackle and improve current and emerging healthcare needs and make Adelphi an even stronger thought leader in healthcare.

CHI’s Oncology Clinical Trials: Bringing Targeted & Tailored Cancer Therapy will take place on Feb. 21-23, 2012 at the Moscone in San Francisco, CA. This conference is part of the many program options available at the Molecular Med TRI-CON 2012.

Christopher P. Austin, M.D., Scientific Director, NIH Center for Translational Therapeutics, will deliver the keynote presentation at CHI’s Predictive Functional Human Tissue Models conference scheduled on November 17-18, 2011, Boston, MA.

Cambridge Healthtech Institute (CHI) is pleased to offer this pre-conference short course on Tuesday, November 15 at the DoubleTree Hotel in Bethesda, MD.

Laptop became an inseparable thing of our daily work, wherever we go we always bring our laptop inside the bag……

Delegates now have the option to choose from 9 moderated breakout discussion groups at this conference that is set for October 3-4, 2011, Cambridge, MA (part of CHI's Barnett Clinical Summit: Optimizing Trial Management).

Cambridge Healthtech Institute announces three sponsors and presenters at upcoming conference set for November 3-5, 2011 in Philadelphia: Biovista, Cetero Research, and Lotus Clinical Research, LLC.

3 hour course to be held in Boston on November 17 lead by David Kaplan, Ph.D., Tufts University; Melik Demirel, Ph.D., Pennsylvania University; Derek J. Hansford, Ph.D., Ohio State University; and Umut A. Gurkan, Ph.D., Harvard-MIT.

Early registration discounts (up to $400 off a conference registration) will be offered until August 26.

This summit (part of CHI's Third Annual Immunogenicity Summit) is scheduled for November 17-18, 2011 at the DoubleTree Hotel in Bethesda, MD.

This year’s theme is about moving into the third dimension of drug discovery and development. This conference will take place on November 17-18, 2011 in Boston, MA. Early registration discounts will be offered until August 26.

This summit (part of CHI's Third Annual Immunogenicity Summit) is scheduled for November 16-17, 2011 at the DoubleTree Hotel in Bethesda, MD.

CHI/Barnett International to hold 3 hour course on October 3, 2011 at the Boston Cambridge Marriott in Cambridge, MA, as part of its Barnett Clinical Summit: Optimizing Trial Management - www.BarnettClinicalSummit.com

3 hour course to be held in Philadelphia on October 3, 2011, by John Arrowsmith, Ph.D., Science Director, Europe, Thomson Life Sciences Consulting & Richard K. Harrison, Ph.D., Scientific Director, North America, Thomson Life Sciences Consulting

A 2-part event covering developments in assay technologies, risk assessment, regulatory guidance and means of predicting and avoiding immunogenicity. Early registration discounts will be offered until August 26.

Cambridge Healthtech Institute and Barnett International today announced that its Inaugural Site Performance conference will be part of its Barnett Clinical Summit: Optimizing Trial Management.

Cambridge Healthtech Institute and Barnett International today announced that its Inaugural Clinical Protocol Optimization conference will be part of its Barnett Clinical Summit: Optimizing Trial Management.

Cambridge Healthtech Institute will be hosting the 2nd Annual Companion Diagnostics as an Integral Part of Personalized Medicine Conference in Washington, DC on August 24-25, 2011. This conference is part of CHI’s Next Generation Dx Summit.

This conference will take place on Aug. 16-17, 2011, Cambridge, MA. Experts from vaccine manufacturers, suppliers, quality control, and platform development gather to learn new technologies & advance the field of vaccine & therapeutic manufacturing.

Today, Inovio Pharmaceuticals reports long-term immune responses from therapeutic cervical dysplasia and cancer DNA vaccine. Mark Bagarazzi, M.D., Chief Medical Officer, will speak at CHI's Clinical Development of Vaccines conference.

CHI and Bio-IT World's "Structure-Based Design" Conference to be held on June 8-10, 2011 in Cambridge, MA, will feature a new session: New Targets and Drug Modalities

CHI and Bio-IT World's "Structure-Based Design" Conference to be held on June 8-10, 2011 in Cambridge, MA, will feature a new session: Fragment-Based Drug Design

Featuring 12 conference programs within 4 streams focused on the current trends and science in antibody engineering and development (PEGSummit.com).

Sun Born Natural Products Company’s Herbal Chi Balm gains more ground in professional sports

New report available at InsightPharmaReports.com

This book is a full-color biography/travel essay that contains the poetry, prose and artwork of Tanya Orme, a young and soulful adventurer who shunned a conventional lifestyle and traveled the globe by modest means on a journey of self-discovery.

Chan Chin C. Enterprise Co., Ltd, a 20-year screw manufacturer from the “Kingdom of Fasteners”, takes the next step into global market by attending Feicon & Batimat Brazil 2010

Salon Stewart, a full service salon located in Riverview, Michigan (MI) is announcing the opening of its new online store offering salon products for sale online.